237 results on '"Robertson, J. F. R."'
Search Results
2. erbB Signalling and Endocrine Sensitivity of Human Breast Cancer
3. Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience
4. Male breast cancer: a review of clinical management
5. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
6. A gene-expression signature to predict survival in breast cancer across independent data sets
7. Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
8. A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up
9. The sequential use of endocrine treatment for advanced breast cancer: where are we?
10. Clinical validation of an autoantibody test for lung cancer
11. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer
12. Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer
13. Sir Peter Freyer Memorial Lecture and Surgical Symposium 15th and 16th September, 1995
14. Seventeenth Sir Peter Freyer memorial lecture and surgical symposium: September 23rd & 24th, 1993
15. Prospective assessment of the role of five tumour markers in breast cancer
16. Cellular effects of tamoxifen in primary breast cancer
17. Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11
18. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma
19. HER-2 in node-negative breast carcinoma: prognostic significance
20. Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
21. The missing mammographic abnormality
22. OMENTAL TRANSPOSITION FLAP FOR GROSS LOCALLY RECURRENT BREAST CANCER
23. DIAGNOSIS OF BREAST CANCER WITH CORE-BIOPSY AND FINE NEEDLE ASPIRATION CYTOLOGY
24. BCL2 expression in breast cancer: identification of patients who should not receive endocrine therapy
25. Healed Paget's disease of the nipple
26. Micrometastases In Bone Marrow In Patients With Breast Cancer
27. Comparison Of Mastectomy With Tamoxifen For Treating Elderly Patients With Operable Breast Cancer
28. Factors influencing the decision to attend screening for cancer in the UK: a meta-ethnography of qualitative research
29. ICI 182,780 (Fulvestrant™) – the first oestrogen receptor down-regulator – current clinical data
30. Factors influencing the decision to attend screening for cancer in the UK: a meta-ethnography of qualitative research.
31. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
32. Expression of Ras P21, P53 and C-Erbb-2 in Advanced Breast-Cancer and Response to First Line Hormonal-Therapy
33. IGF-1R expression and activation in clinical breast cancer
34. A randomized controlled trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with breast carcinoma of high estrogen receptor content: Long-term results at 20 years of follow-up.
35. Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience
36. Male breast cancer: a review of clinical management
37. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
38. A gene-expression signature to predict survival in breast cancer across independent data sets
39. The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast
40. Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre
41. Overview of tyrosine kinase inhibitors in clinical breast cancer
42. Consensus Statement
43. Autoantibodies in early breast cancer
44. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma
45. Biological markers associated with response to gefitinib (ZD1839) in patients with breast cancer
46. Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials
47. Fulvestrant: pharmacokinetics and pharmacology
48. Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer
49. Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features
50. Prognostic factors for patients with hepatic metastases from breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.